BAB 6 KESIMPULAN DAN SARAN
6.2. Saran
6.2. Saran
1. Perlu dilakukan penelitian serupa dengan jumlah sampel yang lebih banyak agar diperoleh hasil yang lebih representatif.
2. Perlu dilakukan penelitian lebih lanjut pada manusia untuk mendapatkan data yang lebih dipercaya sehingga penggunaannya lebih efektif.
3. Hasil penelitian ini diharapkan dapat menjadi acuan bagi pihak tenaga medis, baik dokter maupun perawat dalam rangka untuk menangani penyakit jantung dan pembuluh darah, sehingga dapat meningkatkan kualitas hidup penderita penyakit tersebut.
DAFTAR PUSTAKA
Ahmed, A., et al., 2011. Effect of Natural Honey on Human Platelets and Blood Coagulation Proteins. Pak. J. Pharm. Sci., 24 (3): 389-397.
Akhlaghi, M., Bandy, B., 2009. Mechanisms of flavonoid protection against myocardial ischemia-reperfusion injury. Journal of Molecular and Cellular Cardiology, 46: 309-317.
Alvarez-Suarez, J.M., Gasparrini, M., Forbes-Hernández, T.Y., Mazzoni, L., Giampieri, F., 2014. Review: The Composition and Biological Activity of Honey: A Focus on Manuka Honey. Foods, 3: 420-432.
Antithrombotic Trialists’ Collaboration, 2002. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. British Medical Journal, 324: 71-86. Barrett, K.E., Barman, S.M., Boitano, S., Brooks, H.L., 2012. Blood as a Circulatory Fluids & the Dynamics of Blood & Lymph Flow. Dalam: Ganong’s Review of Medical Physiology. 24th ed. USA: McGraw-Hill, 565.
Bogdanov, S., Jurendic, T., Sieber, R., Gallmann, P., 2008. Honey for nutrition and health: A review. J. Am. Coll. Nutr., 27: 677-689.
Bojic, M., Debeljak, Z., Tomicic, M., Medic-Saric, M., Tomic, S., 2011. Evaluation of antiaggregatory activity of flavonoid aglycone series. Nutrition Journal, 10: 73.
Castro, S.L., 2001. Propolis: Biological and Pharmacological Activities. Therapeutic Uses of this Bee-product. ARBS Annual Rev. Biomed. Sci., 3: 49-83.
Chen, T., et al., 2007. Antiplatelet Activity of Caffeic Acid Phenethyl Ester Is Mediated through a Cyclic GMP-Dependent Pathway in Human Platelets. Chinese Journal of Physiology, 50 (3): 121-126.
Codex Stan 12-1981. Revised Codex Standard for Honey. Codex Stan 12-1981, Rev. 1 (1987), Rev. 2 (2001). Diunduh dari:
www.codexalimentarius.org/input/download/standards/310/cxs_012e.pdf. [Diakses pada 5 April 2015].
Eteraf-Oskouei, T., Najafi, M., 2013. Traditional and Modern Uses of Natural Honey In Human Diseases: A Review. Iran J Basic Med Sci, 16: 731-742.
Farooqui, T., 2009. Honey: An Anti-Aging Remedy to Keep you Healthy in a Natural Way. Diunduh dari:
http://www.scienceboard.net/community/perspectives.228.html. [Diakses pada 23 May 2015].
Farooqui, T., Farooqui, A.A., 2014. Honey for Cardiovascular Disease. Dalam: Boukraa, L., 2014. Honey in Traditional and Modern Medicine. USA: Taylor & Francis Group, 187-216.
Farrugia, C.A., 1999. The Antiplatelet Activity of Aspirin. The chronic ill, 3: 14-18. Federer, W.Y., 1963. Experimental Design, Theory and Application. New York: Mac. Millan: 544.
Ferroni, P., Basili, S., Falco, A., Davi, G., 2004. Oxidant stress and platelet activation in hypercholesterolemia. Antioxid. Redox. Signal, 6 (4): 747-756.
Gomez-Caravaca, A.M., Gomez-Romero, M., Arraez-Roman, D., Segura-Carretero, A., Fernandez-Gutierrez, A., 2006. Advances in the analysis of phenolic compounds in products derived from bees. Journal of Pharmaceutical and
Havsteen, B.H., 2002. The biochemistry and medical significance of the flavonoids. Pharmacol. Ther., 96: 67-202.
Hegazi, A.G., El-Hady, F.K.A., 2009. Influence of Honey on the Suppression of Human Low Density Lipoprotein (LDL) Peroxidation (In vitro). eCAM, 6 (1): 113-121.
Howland, R.D., Mycek, M.J., 2006. Drugs Affecting The Blood. Dalam: Lippincott’s
Illustrated Reviews: Pharmacology. 3rd ed. USA: Williams & Wilkins, 227-244. Ivashchenko, M.N., Samodelkin, A.G., 2014. Effect of Propolis on Platelet Aggregation. Biological Sciences. Fundamental Research, 12: 2146-2149.
Jin, Y., 2007. Antiplatelet activity of hesperetin, a bioflavonoid, is mainly mediated by inhibition of PLC-γ2 phosphorylation and cyclooxygenase-1 activity. Atherosclerosis, 194: 144-152.
Krell, R., 1996. Honey. Value Added Products From Beekeeping. FAO Agricultural Services Bulletin. Food and Agriculture Organization of the United Nation. 124: 16-23.
Krell, R., 1996. Propolis. Value Added Products From Beekeeping. FAO Agricultural Services Bulletin. Food and Agriculture Organization of the United Nation. 124: 153-157.
Laurence, D.R., Bacharach, A.L., 1964. Evaluation of drug activities: Pharmacometrics. New York: Academic Press, 1: 196.
Litovitz, T.L., et al., 2001. Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. American Journal of
Longo, D.L., et al., 2012. Arterial and Venous Thrombosis. Dalam: Harrison’s
Principles of Internal Medicine. 18th ed. USA: McGraw-Hill, 117.
Ndagu, L.F., Arjana, A.A., Berata, I.K., 2013. Madu Berefek Protektif Terhadap Infiltrasi Sel Radang dan Perdarahan Ginjal Akibat Induksi Aspirin. Indonesia
Medicus Veterinus, 2 (1): 102-114.
OECD/WHO, 2014. Mortality from cardiovascular disease. In: Health at a Glance: Asia/Pacific 2014: Measuring Progress towards Universal Health Coverage,
OECD Publishing: 22-23.
Olaitan, P.B., Adeleke, O.E., Ola, I.O., 2007. Honey: a reservoir for microorganisms and an inhibitory agent for microbes. African Health Sciences, 7 (3): 159-165. Patrono, C., et al., 2004. Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. CHEST, 126 (3): 234S-264S.
Rang, H.P., Dale, M.M., Ritter, J.M., Flower, R.J., Henderson, G., 2012. Haemostasis and thrombosis. Dalam: Rang & Dale’s Pharmacology. 7th ed. Spain: 294-308. Rosmiati, H., Gan, V.H.S., 1995. Antikoagulan, Antitrombosit, Trombolitik dan Hemostatik. Dalam: Ganiswara, S.G., Setiabudy, R., Suyatna, F.D., Purwantyastuti, 1995. Farmakologi dan Terapi, edisi ke-4. Jakarta: Gaya Baru, 747-761.
Salatino, A., Teixeira, E.W., Negri, G., Message, D., 2005. Review: Origin and Chemical Variation of Brazilian Propolis. eCAM, 2 (1): 33-38.
Suharti, C., 2009. Dasar-dasar Hemostasis. Dalam: Sudoyo, A.W., Setiyohadi, B., Alwi, I., Simadibrata, M., Setiati, S., 2009. Ilmu Penyakit Dalam, edisi ke-5, Jilid II. Jakarta: 1293-1300.
Tambunan, K.L., 2009. Patogenesis Trombosis. Dalam: Sudoyo, A.W., Setiyohadi, B., Alwi, I., Simadibrata, M., Setiati, S., 2009. Ilmu Penyakit Dalam, edisi ke-5, Jilid II. Jakarta: 1301-1306.
Tortora, G.J., Derrickson, B., 2011. The Cardiovascular System: The Blood. Dalam: Principles of Anatomy & Physiology: Maintenance and Continuity of the Human
Body. 13th ed. Volume 2. Asia: John Wiley & Sons, Inc., 728-756.
Tripathi, K.D., 2008. Nonsteroidal Antiinflammatory Drugs and Antipyretic- Analgesics. Dalam: Essentials of Medical Pharmacology. 6th ed. New Delhi: Jaypee Brothers Medical Publishers, 187-189.
WHO, 2007. Prevention of Cardiovascular Disease: Pocket Guidelines for Assessment and Management of Cardiovascular Risk: WHO/ISH Cardiovascular Risk Prediction Charts for the African Region. Diunduh dari: http://www.who.int/cardiovascular_diseases/guidelines/PocketGL.ENGLISH. AFR-D-E.rev1.pdf. [Diakses pada 23 April 2015].
WHO, 2012. NCD mortality and morbidity. WHO. Diunduh dari: http://www.who.int/gho/ncd/mortality_morbidity/en/. [Diakses pada 14 April 2015].
WHO-Noncommunicable Diseases (NCD) Country Profiles, 2014. Indonesia. Diunduh dari: www.who.int/nmh/countries/idn_en.pdf. [Diakses pada
LAMPIRAN 1
DAFTAR RIWAYAT HIDUP
Nama : Logaselvi A/P Ramar NIM : 120100521
Jenis Kelamin : Perempuan
Tempat / Tanggal Lahir : Negeri Sembilan, Malaysia / 14 Oktober 1992 Nomor Telepon / Email : 083199456171 / logasweet_92@yahoo.com Pekerjaan : Mahasiswa
Agama : Hindu
Alamat : Jln. Dr. Mansyur, No. 3A, Medan Riwayat Pendidikan : Sijil Pelajaran Malaysia (SPM) – 2009
: Sijil Tinggi Pelajaran Malaysia (STPM) – 2011 : Fakultas Kedokteran USU – sekarang
Riwayat Organisasi : Ahli, Persatuan Kebangsaan Pelajar-pelajar Malaysia Indonesia Cawangan Medan (PKPMI-CM).
LAMPIRAN 4 : DATA INDUK
MENCIT NAMA OBAT WAKTU
PERDARAHAN (DETIK) HASIL 1 Plasebo 116 Normal 2 Plasebo 100 Normal 3 Plasebo 103 Normal 4 Plasebo 114 Normal 5 Plasebo 125 Normal 6 Plasebo 74 Normal 7 Plasebo 91 Normal 8 Plasebo 100 Normal 9 Aspirin 232 Memanjang 10 Aspirin 273 Memanjang 11 Aspirin 452 Memanjang 12 Aspirin 352 Memanjang 13 Aspirin 507 Memanjang 14 Aspirin 470 Memanjang 15 Aspirin 468 Memanjang 16 Aspirin 201 Memanjang 17 Propolis 536 Memanjang 18 Propolis 511 Memanjang 19 Propolis 434 Memanjang 20 Propolis 450 Memanjang 21 Propolis 248 Memanjang 22 Propolis 269 Memanjang
23 Propolis 327 Memanjang 24 Propolis 312 Memanjang 25 Madu 338 Memanjang 26 Madu 179 Normal 27 Madu 315 Memanjang 28 Madu 433 Memanjang 29 Madu 449 Memanjang 30 Madu 129 Normal 31 Madu 462 Memanjang 32 Madu 132 Normal
WAKTU PERDARAHAN MENCIT (DETIK) Descriptives WaktuPerdarahan N Mean Std. Deviation Std. Error
95% Confidence Interval for Mean
Minimum Maximum
Lower Bound Upper Bound
Placebo 8 102.88 15.932 5.633 89.56 116.19 74 125
Aspirin 8 369.38 120.967 42.768 268.24 470.51 201 507
Propolis 8 385.88 110.979 39.237 293.09 478.66 248 536
Madu 8 304.63 141.289 49.953 186.50 422.75 129 462
Total 32 290.69 154.076 27.237 235.14 346.24 74 536
UJI NORMALITAS WAKTU PERDARAHAN
Tests of Normality
NamaObat Kolmogorov-Smirnova Shapiro-Wilk
Statistic df Sig. Statistic df Sig.
WaktuPerdarahan
Placebo .178 8 .200* .964 8 .847
Aspirin .253 8 .142 .880 8 .188
Propolis .202 8 .200* .916 8 .398
Madu .193 8 .200* .864 8 .133
*. This is a lower bound of the true significance. a. Lilliefors Significance Correction
UJI HOMOGENITAS WAKTU PERDARAHAN
Test of Homogeneity of Variances WaktuPerdarahan
Levene Statistic df1 df2 Sig.
ANOVA WaktuPerdarahan
Sum of Squares df Mean Square F Sig.
Between Groups 405761.375 3 135253.792 11.470 .000
Within Groups 330161.500 28 11791.482
Total 735922.875 31
UJI KRUSKAL WALLIS
Test Statisticsa,b
WaktuPerdaraha n
Chi-Square 18.586
df 3
Asymp. Sig. .000
a. Kruskal Wallis Test
b. Grouping Variable: NamaObat
UJI MANN WHITNEY Placebo dan Aspirin
Ranks
NamaObat N Mean Rank Sum of Ranks
WaktuPerdarahan
Placebo 8 4.50 36.00
Aspirin 8 12.50 100.00
Test Statisticsa WaktuPerdaraha n Mann-Whitney U .000 Wilcoxon W 36.000 Z -3.363
Asymp. Sig. (2-tailed) .001
Exact Sig. [2*(1-tailed Sig.)] .000b
a. Grouping Variable: NamaObat b. Not corrected for ties.
Placebo dan Propolis
Ranks
NamaObat N Mean Rank Sum of Ranks
WaktuPerdarahan Placebo 8 4.50 36.00 Propolis 8 12.50 100.00 Total 16 Test Statisticsa WaktuPerdaraha n Mann-Whitney U .000 Wilcoxon W 36.000 Z -3.363
Asymp. Sig. (2-tailed) .001
Exact Sig. [2*(1-tailed Sig.)] .000b
a. Grouping Variable: NamaObat b. Not corrected for ties.
Placebo dan Madu
Ranks
NamaObat N Mean Rank Sum of Ranks
WaktuPerdarahan Placebo 8 4.50 36.00 Madu 8 12.50 100.00 Total 16 Test Statisticsa WaktuPerdaraha n Mann-Whitney U .000 Wilcoxon W 36.000 Z -3.363
Asymp. Sig. (2-tailed) .001
Exact Sig. [2*(1-tailed Sig.)] .000b
a. Grouping Variable: NamaObat b. Not corrected for ties.
Aspirin dan Propolis
Ranks
NamaObat N Mean Rank Sum of Ranks
WaktuPerdarahan
Aspirin 8 8.25 66.00
Propolis 8 8.75 70.00
Test Statisticsa WaktuPerdaraha n Mann-Whitney U 30.000 Wilcoxon W 66.000 Z -.210
Asymp. Sig. (2-tailed) .834
Exact Sig. [2*(1-tailed Sig.)] .878b
a. Grouping Variable: NamaObat b. Not corrected for ties.
Aspirin dan Madu
Ranks
NamaObat N Mean Rank Sum of Ranks
WaktuPerdarahan Aspirin 8 10.13 81.00 Madu 8 6.88 55.00 Total 16 Test Statisticsa WaktuPerdaraha n Mann-Whitney U 19.000 Wilcoxon W 55.000 Z -1.365
Asymp. Sig. (2-tailed) .172
Exact Sig. [2*(1-tailed Sig.)] .195b
a. Grouping Variable: NamaObat b. Not corrected for ties.
Propolis dan Madu
Ranks
NamaObat N Mean Rank Sum of Ranks
WaktuPerdarahan Propolis 8 9.75 78.00 Madu 8 7.25 58.00 Total 16 Test Statisticsa WaktuPerdaraha n Mann-Whitney U 22.000 Wilcoxon W 58.000 Z -1.050
Asymp. Sig. (2-tailed) .294
Exact Sig. [2*(1-tailed Sig.)] .328b
a. Grouping Variable: NamaObat b. Not corrected for ties.